Announcement
Mavengity Expands into B2B Research
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the Article
Posted in the last 24 hours
Fresh from the desks
Fintech
Revolut's US Charter Approval Is the Easy Part
Revolut cleared a major hurdle toward a US national bank charter, but the conditions, the capital, and the deposit base are the real test.
Private markets
The $450 Million Lesson in Pre-IPO Pricing
Federal charges against two former Linqto CEOs show what happens when a private-share platform sets the price, and the investor has no way to check it.
Non-QM lending
One in Ten Mortgages Now Sits Outside the Qualified Mortgage Box
Non-QM lending reached $239 billion in 2025, a tenth of all US originations, and the fastest growth comes from self-employed borrowers and investors the rules never learned to see.
Fair lending
California Is Building a Second Fair-Lending Regulator
With federal fair-lending enforcement in retreat, a bill on Governor Newsom's desk would give California examiners their own four-year inspection cycle over mortgage lenders.
Legal tech
One Vendor's Incident Touched Court Records in 11 States
A cybersecurity incident at Thomson Reuters' C-Track platform shows what happens when a decade of court digitization funnels millions of case files through a handful of vendor clouds.
Privacy
California Just Retired Its Most Misused Wiretap Law
A law written for phone taps became the engine of 4,000 lawsuits over website analytics. SB 690 shuts that engine down, and the litigation is already migrating to the next theory.
Diagnostics
An Alzheimer's Blood Test Now Sits in Primary Care's Hands
The FDA's newly cleared pTau217 blood test moves Alzheimer's evaluation from imaging centers into ordinary doctor's offices, where the system's real bottleneck has always been.
Biosimilars
The Keytruda Biosimilar Race Will Be Decided in Factories
Cipla and Qilu's exclusive deal for a US pembrolizumab biosimilar splits the work into manufacturing and selling, which says more about the coming competition than any approval date.
Antitrust
Amazon's Ad Auction Ran on a Bidder That Did Not Exist
The FTC and 22 states say Amazon's "second-price" ad auction quietly stopped being second-price. The case turns on a price that was never printed.
B2B Research
Most Popular Research Articles
Intent Data
Intent Data Providers For B2B
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
Knowledge Management
Knowledge Management Solutions
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
MDR
Managed Detection And Response Services
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
MDR Europe
Managed Detection And Response Services In Europe
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Manufacturing Tech
Manufacturing Technology Services
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Market Intelligence
Market And Competitive Intelligence Platforms
Generative AI should have commoditized this category, and instead Forrester's criteria count kept climbing, because the moat was always licensed source access, not summarization.
Open Banking
Open Banking Intermediaries
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Change Management
Organizational Change Management Services
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
PLM
Product Lifecycle Management Platforms For Discrete Manufacturers
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Announcements
News from Mavengity
Announcement
James T. Joins Mavengity as a Medical Writer
With James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article
Browse by topic
Where would you like to start?
Every article on Mavengity is written by a dedicated topic desk and checked against current market practice.
Insurance
Home, auto, life, and health coverage, explained clearly and checked against the fine print.
Browse InsuranceMortgage
Rates, refinancing, and first-time buyer strategy, without the jargon lenders assume you already know.
Browse MortgagePersonal Finance
Budgeting, saving, and everyday money habits that compound. No get-rich-quick promises.
Browse Personal FinanceLegal
Contracts, consumer rights, and disputes, explained so you know where you stand.
Browse LegalHealthcare & Medical
Health coverage and medical billing, broken down so surprise bills are less likely to surprise you.
Browse HealthcareResearch
Gartner and Forrester categories for B2B, translated into plain-English analysis for buyers, not analyst-subscription holders.
Browse Research
Why Mavengity
Editorial standards you can check
Independently researched
We start from public rate filings, regulator guidance, and lender disclosures, not marketing copy.
Plain-English explanations
If a term needs a footnote, we explain it in the sentence instead of hiding it in the fine print.
Straight, not slanted
We flag trade-offs and blind spots, not just the upside, so you get the full picture before you decide.
Written for readers, not lenders
Mavengity is reader-supported and editorially independent from the products we cover.